Inhibikase Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $139k | 86k | 1.62 |
| 2025-06-30 | $215k | 110k | 1.95 |
| 2025-03-31 | $184k | 84k | 2.19 |
| 2024-12-31 | $273k | 84k | 3.25 |
| 2023-06-30 | $41k | 12k | 3.58 |